Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2.
ACE2 affinity
BA.4
BA.5
COVID-19
Omicron
RBD
SARS-CoV-2
Spike glycoprotein
temperature
variant of concern
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
30 09 2022
30 09 2022
Historique:
received:
31
08
2022
revised:
22
09
2022
accepted:
29
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
SARS-CoV-2 continues to infect millions of people worldwide. The subvariants arising from the variant-of-concern (VOC) Omicron include BA.1, BA.1.1, BA.2, BA.2.12.1, BA.4, and BA.5. All possess multiple mutations in their Spike glycoprotein, notably in its immunogenic receptor-binding domain (RBD), and present enhanced viral transmission. The highly mutated Spike glycoproteins from these subvariants present different degrees of resistance to recognition and cross-neutralisation by plasma from previously infected and/or vaccinated individuals. We have recently shown that the temperature affects the interaction between the Spike and its receptor, the angiotensin converting enzyme 2 (ACE2). The affinity of RBD for ACE2 is significantly increased at lower temperatures. However, whether this is also observed with the Spike of Omicron and sub-lineages is not known. Here we show that, similar to other variants, Spikes from Omicron sub-lineages bind better the ACE2 receptor at lower temperatures. Whether this translates into enhanced transmission during the fall and winter seasons remains to be determined.
Identifiants
pubmed: 36298733
pii: v14102178
doi: 10.3390/v14102178
pmc: PMC9607596
pii:
doi:
Substances chimiques
Angiotensin-Converting Enzyme 2
EC 3.4.17.23
Spike Glycoprotein, Coronavirus
0
Peptidyl-Dipeptidase A
EC 3.4.15.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CIHR
ID : Operating grant
Pays : Canada
Organisme : CIHR
ID : Fellowship
Pays : Canada
Références
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Sustain Cities Soc. 2022 Jun;81:103840
pubmed: 35317188
iScience. 2022 Jul 15;25(7):104528
pubmed: 35677392
Adv Virus Res. 2019;105:93-116
pubmed: 31522710
Cell Rep. 2022 Mar 1;38(9):110429
pubmed: 35216664
Viruses. 2020 Sep 29;12(10):
pubmed: 33003587
Nat Methods. 2023 Apr;20(4):536-540
pubmed: 36823331
Cell Host Microbe. 2022 Aug 10;30(8):1093-1102.e3
pubmed: 35526534
mBio. 2022 Feb 15;13(1):e0322721
pubmed: 35164561
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Cell. 2021 Jun 24;184(13):3426-3437.e8
pubmed: 33991487
Mol Cell. 2022 Jun 2;82(11):2050-2068.e6
pubmed: 35447081
Cell Rep. 2022 May 3;39(5):110770
pubmed: 35477022
Cell. 2022 Jun 9;185(12):2103-2115.e19
pubmed: 35568035
Science. 2022 Aug 19;377(6608):890-894
pubmed: 35857529
N Engl J Med. 2022 Jun 30;386(26):2526-2528
pubmed: 35704428
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Front Immunol. 2021 Dec 22;12:732690
pubmed: 35003058
Nat Methods. 2023 Apr;20(4):512-522
pubmed: 36823332
Cell. 2022 Feb 3;185(3):467-484.e15
pubmed: 35081335
Viruses. 2020 Oct 26;12(11):
pubmed: 33114742
Nature. 2022 Feb;602(7898):671-675
pubmed: 35016199
Virology. 2021 Nov;563:134-145
pubmed: 34536797
Cell Rep. 2022 Jan 11;38(2):110210
pubmed: 34971573
Nature. 2020 May;581(7807):221-224
pubmed: 32225175
Cell Host Microbe. 2020 Dec 9;28(6):880-891.e8
pubmed: 33242391
mBio. 2020 Oct 16;11(5):
pubmed: 33067385
Cold Spring Harb Perspect Med. 2022 May 27;12(5):
pubmed: 35444005
Nat Struct Mol Biol. 2022 Mar;29(3):229-238
pubmed: 35236990
Science. 2020 Sep 25;369(6511):1586-1592
pubmed: 32694201
J Infect Dis. 2023 Apr 26;227(9):1073-1083
pubmed: 36645782
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Nat Commun. 2022 Aug 24;13(1):4958
pubmed: 36002453
Int J Mol Sci. 2022 May 29;23(11):
pubmed: 35682761
Cell Host Microbe. 2021 Mar 10;29(3):322-324
pubmed: 33705702
Cell. 2021 Aug 5;184(16):4220-4236.e13
pubmed: 34242578
Nat Struct Mol Biol. 2020 Oct;27(10):925-933
pubmed: 32699321
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Cell Rep. 2022 Jun 28;39(13):111009
pubmed: 35732171
J Virol. 1991 Mar;65(3):1202-7
pubmed: 1847450
Rev Med Virol. 2022 Sep;32(5):e2381
pubmed: 35856385
J Biol Chem. 2021 Oct;297(4):101151
pubmed: 34478710
Cell Rep. 2022 Jun 14;39(11):110924
pubmed: 35658975
N Engl J Med. 2022 Jul 7;387(1):86-88
pubmed: 35731894
Immunity. 2021 Sep 14;54(9):2143-2158.e15
pubmed: 34453881
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Science. 2022 Feb 25;375(6583):864-868
pubmed: 35076256
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
J Med Virol. 2023 Jan;95(1):e28284
pubmed: 36333837
Cell. 2019 Feb 21;176(5):1026-1039.e15
pubmed: 30712865
Elife. 2022 Mar 24;11:
pubmed: 35323111